NCT06915766 2026-03-09Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic MastocytosisCogent Biosciences, Inc.Available
NCT04681105 2026-01-28Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological MalignanciesCity of Hope Medical CenterPhase 1 Completed13 enrolled